An expert system for the evaluation of EDSS in multiple sclerosis

Mauro Gaspari, Gianluigi Roveda, Cinzia Scandellari, Sergio Stecchi

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Multiple sclerosis is a disease of unknown aetiology. Despite several advances in therapy in recent years, some problems such as the prognostic criteria are imperfectly understood. Several experimental trials of therapy in multiple sclerosis are in course in order to discover a successful treatment. Most of these research studies use a clinical rating scale named Expanded Disability Status Scale (EDSS) as an evaluation tool for the effects of drugs. This scale is defined by a set of rules written in English which provide a numerical quantification of the neurological examination. Although EDSS has been widely used for almost 20 years, its application still depends on the interpretation of the neurologist who performs the neurological examination, and many applications of the scale performed by different neurologist on the same patient can give different results. This is a serious problem for international trials because they lack of a reliable measure of the effects of drugs. Here, we present an expert system for the automatic evaluation of EDSS in multiple sclerosis, which has been developed to overcome this problem. The expert system exploits an explicit representation of EDSS rules, it is able to explain its conclusions and it provides a revision tool to support the user if no satisfying solution can be reached. Using this expert system, clinical trials based on EDSS can benefit of a more reliable evaluation tool providing more valuable results.

Original languageEnglish
Pages (from-to)187-210
Number of pages24
JournalArtificial Intelligence in Medicine
Volume25
Issue number2
DOIs
Publication statusPublished - 2002

Fingerprint

Disability Evaluation
Expert Systems
Expert systems
Multiple Sclerosis
Neurologic Examination
Investigational Therapies
Pharmaceutical Preparations
Clinical Trials
Therapeutics
Research
Neurologists

Keywords

  • EDSS
  • Expanded Disability Status Scale
  • Expert system
  • Multiple sclerosis
  • Prolog

ASJC Scopus subject areas

  • Artificial Intelligence
  • Medicine(all)

Cite this

An expert system for the evaluation of EDSS in multiple sclerosis. / Gaspari, Mauro; Roveda, Gianluigi; Scandellari, Cinzia; Stecchi, Sergio.

In: Artificial Intelligence in Medicine, Vol. 25, No. 2, 2002, p. 187-210.

Research output: Contribution to journalArticle

Gaspari, Mauro ; Roveda, Gianluigi ; Scandellari, Cinzia ; Stecchi, Sergio. / An expert system for the evaluation of EDSS in multiple sclerosis. In: Artificial Intelligence in Medicine. 2002 ; Vol. 25, No. 2. pp. 187-210.
@article{17c7add9f3b84592ae1cd55959d8c5c9,
title = "An expert system for the evaluation of EDSS in multiple sclerosis",
abstract = "Multiple sclerosis is a disease of unknown aetiology. Despite several advances in therapy in recent years, some problems such as the prognostic criteria are imperfectly understood. Several experimental trials of therapy in multiple sclerosis are in course in order to discover a successful treatment. Most of these research studies use a clinical rating scale named Expanded Disability Status Scale (EDSS) as an evaluation tool for the effects of drugs. This scale is defined by a set of rules written in English which provide a numerical quantification of the neurological examination. Although EDSS has been widely used for almost 20 years, its application still depends on the interpretation of the neurologist who performs the neurological examination, and many applications of the scale performed by different neurologist on the same patient can give different results. This is a serious problem for international trials because they lack of a reliable measure of the effects of drugs. Here, we present an expert system for the automatic evaluation of EDSS in multiple sclerosis, which has been developed to overcome this problem. The expert system exploits an explicit representation of EDSS rules, it is able to explain its conclusions and it provides a revision tool to support the user if no satisfying solution can be reached. Using this expert system, clinical trials based on EDSS can benefit of a more reliable evaluation tool providing more valuable results.",
keywords = "EDSS, Expanded Disability Status Scale, Expert system, Multiple sclerosis, Prolog",
author = "Mauro Gaspari and Gianluigi Roveda and Cinzia Scandellari and Sergio Stecchi",
year = "2002",
doi = "10.1016/S0933-3657(02)00015-5",
language = "English",
volume = "25",
pages = "187--210",
journal = "Artificial Intelligence in Medicine",
issn = "0933-3657",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - An expert system for the evaluation of EDSS in multiple sclerosis

AU - Gaspari, Mauro

AU - Roveda, Gianluigi

AU - Scandellari, Cinzia

AU - Stecchi, Sergio

PY - 2002

Y1 - 2002

N2 - Multiple sclerosis is a disease of unknown aetiology. Despite several advances in therapy in recent years, some problems such as the prognostic criteria are imperfectly understood. Several experimental trials of therapy in multiple sclerosis are in course in order to discover a successful treatment. Most of these research studies use a clinical rating scale named Expanded Disability Status Scale (EDSS) as an evaluation tool for the effects of drugs. This scale is defined by a set of rules written in English which provide a numerical quantification of the neurological examination. Although EDSS has been widely used for almost 20 years, its application still depends on the interpretation of the neurologist who performs the neurological examination, and many applications of the scale performed by different neurologist on the same patient can give different results. This is a serious problem for international trials because they lack of a reliable measure of the effects of drugs. Here, we present an expert system for the automatic evaluation of EDSS in multiple sclerosis, which has been developed to overcome this problem. The expert system exploits an explicit representation of EDSS rules, it is able to explain its conclusions and it provides a revision tool to support the user if no satisfying solution can be reached. Using this expert system, clinical trials based on EDSS can benefit of a more reliable evaluation tool providing more valuable results.

AB - Multiple sclerosis is a disease of unknown aetiology. Despite several advances in therapy in recent years, some problems such as the prognostic criteria are imperfectly understood. Several experimental trials of therapy in multiple sclerosis are in course in order to discover a successful treatment. Most of these research studies use a clinical rating scale named Expanded Disability Status Scale (EDSS) as an evaluation tool for the effects of drugs. This scale is defined by a set of rules written in English which provide a numerical quantification of the neurological examination. Although EDSS has been widely used for almost 20 years, its application still depends on the interpretation of the neurologist who performs the neurological examination, and many applications of the scale performed by different neurologist on the same patient can give different results. This is a serious problem for international trials because they lack of a reliable measure of the effects of drugs. Here, we present an expert system for the automatic evaluation of EDSS in multiple sclerosis, which has been developed to overcome this problem. The expert system exploits an explicit representation of EDSS rules, it is able to explain its conclusions and it provides a revision tool to support the user if no satisfying solution can be reached. Using this expert system, clinical trials based on EDSS can benefit of a more reliable evaluation tool providing more valuable results.

KW - EDSS

KW - Expanded Disability Status Scale

KW - Expert system

KW - Multiple sclerosis

KW - Prolog

UR - http://www.scopus.com/inward/record.url?scp=0036107930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036107930&partnerID=8YFLogxK

U2 - 10.1016/S0933-3657(02)00015-5

DO - 10.1016/S0933-3657(02)00015-5

M3 - Article

C2 - 12031606

AN - SCOPUS:0036107930

VL - 25

SP - 187

EP - 210

JO - Artificial Intelligence in Medicine

JF - Artificial Intelligence in Medicine

SN - 0933-3657

IS - 2

ER -